Category Archives: Parkinson’s

Is CAM cost effective treatment?

Three criteria determine drug reimbursement decisions: therapeutic value, cost effectiveness, and burden of disease. Now, an article from Erasmus University in The Netherlands questions whether it’s sufficient for a drug to meet these criteria, and proposes a 4th hurdle.

Consider how CAM would hold up under such scrutiny based on what we know today. Continue reading Is CAM cost effective treatment? →

New study disputes the value of CoQ10 to treat Parkinson’s disease

In 2002, the Parkinson Study Group reported that CoQ10 (coenzyme Q 10) slowed deterioration in patients with early Parkinson’s disease even though it failed to postpone the start of levodopa (Dopar) treatment.

Now, a study in patients with midstage Parkinson’s disease without changes on muscle function and control reports disappointing results. Continue reading New study disputes the value of CoQ10 to treat Parkinson’s disease →

DHEA quality control questioned

“The main voices in favor of DHEA as a miracle drug are those who are selling it or who make a good living selling books or programs advocating ‘natural cures’.” That’s the conclusion from the Skeptics Dictionary. But look for yourself, and you will agree.

Here is another reason to be skeptical of DHEA [dehydroepiandrosterone].

Continue reading DHEA quality control questioned →